🔴 HCW Biologics is trading 12.4% down today with no clear negative catalyst identified

HCW Biologics is trading 12.4% down now at $2.94, with no clear company-specific negative catalyst identified for September 3, 2026.

• The decline continues a sharp reversal from the August 27–28 rally.
• Recent coverage highlighted a positive USPTO patent allowance for HCW9302 and continued Phase 1 progress, making that news an unlikely explanation.
• Biotechnology and major U.S. indexes are higher, so broader market or sector sentiment does not explain the underperformance.